Sources
Loading...
Additional media
Loading...
An Orange County man has pleaded guilty to the felony distribution of an unapproved drug intended to treat serious diseases. This case marks the first successful federal criminal charges against a leader of a stem cell clinic firm in the modern era. The founder and CEO of the injectable stem cell product manufacturer, Liveyon, was found guilty, highlighting ongoing concerns about the marketing of unproven stem cell treatments. The guilty plea underscores the risks posed by unscrupulous providers offering unapproved and unproven umbilical cord blood stem cell products, which have led to adverse events among users. The verdict against the Lung Institute further demonstrates that scammers in this field can be held accountable.